US 9463179
Short acting phenylalkylamine calcium channel blockers and uses thereof
granted A61KA61K31/216A61K31/26
Quick answer
US patent 9463179 (Short acting phenylalkylamine calcium channel blockers and uses thereof) held by Milestone Pharmaceuticals Inc. expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Milestone Pharmaceuticals Inc.
- Grant date
- Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/216, A61K31/26, A61K31/275, A61K31/277